Check out our latest press coverage and announcements. For media inquiries, please contact press@allazohealth.com
AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation. Barriers to therapy initiation…
Read moreAllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board. Mr.…
Read moreAllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced that pharmacy benefits management executive Greg Watanabe will be joining the company’s Advisory Board. Mr.…
Read moreMedicaid managed care plans: Achieve targeted HEDIS measures with improved adherence powered by AI Connect with AllazoHealth, February 5-7, 2020 Medicaid Innovations Forum | Hyatt Regency Grand Cypress | Orlando, Florida The Medicaid Innovations Forum…
Read moreAllazoHealth COO William Grambley explains in this article: “You need to be explicit about AI program constraints upfront. Otherwise you can get to unintended consequences.” “Future of Medicine with Artificial Intelligence,” Biosupply Trends Quarterly, Fall…
Read moreNew York, NY (April 23, 2019) – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Dr. Linda Schultz has joined the company as…
Read moreNEW YORK, NY and FORT MILL, SC (March 4, 2019) – Lash Group, a patient support services company and a part of AmerisourceBergen, and AllazoHealth, an artificial intelligence (AI) and predictive analytics company focused on…
Read moreAllazoHealth and Large Regional Payer Validate Use of Artificial Intelligence in Improving Medication Adherence with Randomized Controlled Study AllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina. The study…
Read moreNew York, NY – AllazoHealth, the AI and predictive analytics company focused on predicting and changing patient behaviors through precision engagement, announced today that Steve Cohan will be joining the company’s Advisory Board. Prior to joining…
Read moreNew York, NY – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Bill Grambley has joined the company as Chief Operating Officer. Prior…
Read more